All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

April 2010 Editor's Picks: Products from Camfil Farr and K-Tron

April 19, 2010
By Pharmaceutical Technology Editors
Article

Equipment and Processing Report

Equipment and Processing ReportEquipment and Processing Report-04-19-2010
Volume 0
Issue 0

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the April 2010 edition from Camfil Farr and K-Tron.

Camfil Farr Air Pollution Control
Dust collector extends filters’ service lives

The Gold Series High Vacuum (GSHV) dust collector from Camfil Farr Air Pollution Control (Jonesboro, AR) controls emissions in applications performed under pressures as high as 17 in. Hg vacuum or 8 psi. The unit is housed in a reinforced dust-capture vessel designed for use as a central vacuum system, positive or negative product receiver, or high-pressure bin vent. The GSHV collector can be provided with two or four Gold Cone HemiPleat filter cartridges, which are available in efficiencies of 99.99% and 99.999% on 0.5-µm particles.

The machine’s cyclonic tangential inlet removes most of the dust as it enters the collector, thus minimizing filters’ contact with the dust and extending their service lives. The device also includes a pulse-cleaning system that operators regulate through a user-friendly, solid-state control panel. The dust collector is available with a horizontal explosion vent for combustible-dust applications and a bag-in–bag-out access door and continuous liner discharge for pharmaceutical dusts.

K-Tron
Material flow aid prevents bridging and rat-holing

K-Tron (Pitman, NJ) offers its ActiFlow bulk-solids activator, a nonproduct contact device that comprises a vibratory drive and an intelligent control unit. The device operates with the K-Tron Control Module (KCM) to activate the material inside the hopper continuously. The KCM unit’s self-tuning algorithm monitors the system and continuously adjusts the ActiFlow’s frequency and amplitude, according to changing material-flow conditions, to maintain flow within the hopper. The activator and KCM thus prevent the formation of bridges and ratholes.

The ActiFlow machine is designed to eliminate the need for mechanical agitators with secondary motors and gearboxes and to eliminate the need for flexible side-wall agitation devices or aeration pads. The ActiFlow device is bolted to the outside of the extension hopper’s rear wall above the feeder, thus reducing headroom requirements. ActiFlow is designed to simplify the cleaning process during material changeover and is suitable for pharmaceutical applications.

Articles in this issue

CamFarr_gshvWEB-664895-1408639865817.jpg
April 2010 Editor's Picks: Products from Camfil Farr and K-Tron
Using Existing Software to Track and Reduce Utility Use
Is Hot Melt Extrusion an Untapped Resource?
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Pharmacopoeia Goes Digital

Susan Haigney
June 25th 2025
Article

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Six Biosimilars Part of EMA’s Authorization Recommendations in June

Susan Haigney
June 23rd 2025
Article

A total of 13 drugs were granted recommendation for market authorization at EMA’s CHMP June 2025 meeting.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


UAE flag waving in the sky, national symbol of UAE | Image Credit: © Freelancer - stock.adobe.com

Abu Dhabi Department of Health Reaches Strategic Agreements During US Mission

Patrick Lavery
June 20th 2025
Article

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.


Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.

Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Pharmacopoeia Goes Digital

Susan Haigney
June 25th 2025
Article

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Six Biosimilars Part of EMA’s Authorization Recommendations in June

Susan Haigney
June 23rd 2025
Article

A total of 13 drugs were granted recommendation for market authorization at EMA’s CHMP June 2025 meeting.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


UAE flag waving in the sky, national symbol of UAE | Image Credit: © Freelancer - stock.adobe.com

Abu Dhabi Department of Health Reaches Strategic Agreements During US Mission

Patrick Lavery
June 20th 2025
Article

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.


Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.